Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

DMK Pharmaceuticals Corp (DMKPQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0350 -0.0010    -2.78%
- Closed. Currency in USD ( Disclaimer )
After Hours
0.0350
0.0000
0.0000%
- Delayed Data
  • Volume: 143,818
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0339 - 0.0496
Type:  Equity
Market:  United States
DMK Pharmaceuticals 0.0350 -0.0010 -2.78%

DMK Pharmaceuticals Company Profile

 
Read the DMK Pharmaceuticals Corp company profile to learn more about the business and the management team. View DMK Pharmaceuticals Corp facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

12

Equity Type

ORD

DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company’s lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California.

Contact Information

Address 11682 El Camino Real Suite 300
San Diego, 92130
United States
Phone 858 997 2400
Fax -

Top Executives

Name Age Since Title
Roshawn A. Blunt 46 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DMKPQ Price Commentary

Write your thoughts about DMK Pharmaceuticals Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
zed razi
zed razi Jun 26, 2021 5:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
road to 1m
Adel Khalfallah
Adel Khalfallah Apr 21, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🙏🏽🙏🏽💎🙌🏽
Mantas KA
Mantas KA Mar 02, 2021 15:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still buy ?
José Carlos Amaral
José Carlos Amaral Jan 22, 2021 15:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it to late to buy in?
Thomas Eriksen
Thomas Eriksen Jan 21, 2021 23:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought 1000 just before closing
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email